From the Dept of Biochemistry, Pasteur Institute of Iran, Tehran , asamadi@kcom.edu
Abstract: (5101 Views)
Human serum paraoxonase (PON) associated with high density lipoprotein
(HDL) , has been postulated to have a role in protecting low-density lipoprotein
(LDL) against oxidative damage, which has led to the proposal that PON is an
anti-atherogenic and anti-inflammatory enzyme. It has genetic polymorphism at
the 191 (R ->Q) and two alloenzymes A and B and three phenotypes A, B, and
AB. We examined the activity of arylesterase and paraoxonase among healthy
individuals and in patients with hypercholesterolemia. Equal activity distribution
was observed among males and females for both enzymes. Arylesterase activity
displayed a normal distribution in the population under study. However,
paraoxonase activity demonstrated a three modal activity. Population distribution
of A, B and AB polymorphism were 46, 10 and 44 percent respectively. A significant
direct correlation between paraoxonase activity and triglyceride levels was
observed (p